Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2000
03/02/2000WO2000010593A1 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS
03/02/2000WO2000010591A1 Peptides for inhibition of herpes simplex virus entry
03/02/2000WO2000010589A1 Somatostatin analogs
03/02/2000WO2000010578A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
03/02/2000WO2000010382A1 Model animal with visualized nerve network
03/02/2000WO1999065513A3 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
03/02/2000WO1999065511A3 Composition and method for treatment of pseudomonas infection
03/02/2000WO1999063093A3 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
03/02/2000WO1999063090A3 Protease inhibitor peptides
03/02/2000WO1999062494A3 Membrane-permeable inhibitor of dynamin-mediated endocytosis
03/02/2000WO1999061635A3 Cotton cells, plants, and seeds genetically engineered to express insecticidal and fungicidal chitin binding proteins (lectins)
03/02/2000WO1999061620A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999061604A3 A vector for gene trap, and a method for gene trapping by using the vector
03/02/2000WO1999060126A3 Protein z-dependent protease inhibitor
03/02/2000WO1999060124A9 Differentiation-associated sequences and methods of use therefor
03/02/2000WO1999059037A9 Methods of determining protein activity levels using gene expression profiles
03/02/2000WO1999058714A3 Method for screening for inhibitors and activators of type iii secretion machinery in gram-negative bacteria
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999058558A3 Cell signaling proteins
03/02/2000WO1999058552A3 Peptides that ellicit t, cellular immunity
03/02/2000WO1999057271A3 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
03/02/2000WO1999057263A9 Modifying the expression of the fsh beta gene by homologous recombination
03/02/2000WO1999057261A3 Human bmp-2 promoter and method for exploring bone-related substance by using the same
03/02/2000WO1999057149A3 Compounds and methods for modulating nonclassical cadherin-mediated functions
03/02/2000WO1999057146A9 Protein mixtures to induce therapeutic angiogenesis
03/02/2000WO1999056767A3 Method for treating cytokine mediated hepatic injury
03/02/2000WO1999055862A3 Human proteins having transmembrane domains and dnas encoding these proteins
03/02/2000WO1999055367A9 INTERNALIZING ErbB2 ANTIBODIES
03/02/2000WO1999054496A3 Method for typing of hla alleles
03/02/2000WO1999054465A3 Gene encoding syntaxin interacting protein
03/02/2000WO1999052563A9 A method for the targeting of proteins produced by yersinia into the cytosol of eukaryotic cells
03/02/2000WO1999049043A3 Human rad17 cell cycle checkpoint
03/02/2000WO1999047668A3 Nucleic acid which codes for tumor suppressor proteins, tumor suppressor proteins, a method for the production thereof, an antibody against tumor suppressor proteins, and the use of these substances
03/02/2000WO1999045947A9 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1999045031A3 Cd147 binding molecules as therapeutics
03/02/2000WO1999037756A8 Non-human animal having a functionally disrupted slp-76 gene
03/02/2000WO1999036535A9 Apo-2 ligand
03/02/2000WO1999024578A3 Neisserial antigens
03/02/2000DE19838837A1 Zellspezifische Promoter des Entkopplungsproteins 3 Cell-specific promoter of uncoupling protein 3
03/02/2000DE19838097A1 Verfahren zur chromatographischen Reinigung von Insulinen Method for the chromatographic purification of insulins
03/02/2000DE19836405C1 Transgene Pflanzen und Pflanzenzellen mit verminderter Expression von Invertaseinhibitoren Transgenic plants and plant cells with reduced expression of invertase
03/02/2000DE19827457C1 Strukturprotein von AAV, seine Herstellung und Verwendung AAV structural protein, its preparation and use
03/02/2000DE19816894C1 SREBP-2-defiziente Zellinien SREBP-2-deficient cell lines
03/02/2000CA2341765A1 Trna binding domain
03/02/2000CA2341637A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2341278A1 Modified synthetic dna sequences for improved insecticidal control
03/02/2000CA2341079A1 Basb024 outer membrane protein of neisseria meningitidis
03/02/2000CA2340884A1 49 human secreted proteins
03/02/2000CA2340787A1 An anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
03/02/2000CA2340616A1 Secreted proteins and polynucleotides encoding them
03/02/2000CA2340595A1 Streptavidin mutants having secondary functional domains
03/02/2000CA2340470A1 Leptin-related peptides
03/02/2000CA2340465A1 Genes that regulate hematopoietic blood forming stem cells and uses thereof
03/02/2000CA2340460A1 A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders
03/02/2000CA2340459A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340456A1 Lats knock-out animal models and their uses
03/02/2000CA2340335A1 Use of suppressor trna's to regulate cytotoxicity during the production of recombinant gene products
03/02/2000CA2340334A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000CA2340330A1 Nucleic acid molecules encoding inclusion membrane protein c of chlamydia
03/02/2000CA2340327A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
03/02/2000CA2340307A1 Artiodactyl epimorphine
03/02/2000CA2340305A1 Hiv suppressor factor derived from scrub typhus
03/02/2000CA2340286A1 Plant expression vector comprising a 5' non-translated leader sequence from a wheat chlorophyll a/b-binding protein gene
03/02/2000CA2340283A1 Nucleic acid molecules encoding pomp91a protein of chlamydia
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000CA2339860A1 Human cell signaling proteins (csig)
03/02/2000CA2339036A1 Tpl-2/cot kinase and methods of use
03/02/2000CA2338837A1 Assays, methods and means for modulating nuclear localisation
03/02/2000CA2337905A1 Targeted alphavirus and alphaviral vectors
03/02/2000CA2335652A1 Polynucleotide sequences
03/02/2000CA2335379A1 Genetic method for the expression of polyproteins in plants
03/02/2000CA2333915A1 Reduction of bowman-birk protease inhibitor levels in plants
03/02/2000CA2306456A1 Deoxyhypusine reagent and peptides
03/01/2000EP0982405A2 Recombinant alphavirus vectors
03/01/2000EP0982403A1 Swine vesicular disease virus and mutant strains and preparation process and use thereof
03/01/2000EP0982402A1 Pestivirus vaccination
03/01/2000EP0982401A2 Drug targets in Candida albicans
03/01/2000EP0982400A1 Human glycine transporter
03/01/2000EP0982399A1 Thyroid hormone transporters, agonists and antagonists thereof
03/01/2000EP0981745A1 The use of a bone morphogenetic protein (bmp) receptor complex for screening
03/01/2000EP0981651A1 Detection of retroviral subtypes based upon envelope specific sequences
03/01/2000EP0981649A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
03/01/2000EP0981637A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
03/01/2000EP0981636A1 Lentivirus-based gene transfer vectors
03/01/2000EP0981635A1 Production of mature proteins in plants
03/01/2000EP0981634A1 PRODUCTION OF SELF-COMPATIBLE $i(BRASSICA) HYBRIDS USING A SELF-INCOMPATIBLE POLLINATION CONTROL SYSTEM
03/01/2000EP0981633A2 Hybrid molecules for optically detecting changes in cellular microenvironments
03/01/2000EP0981627A1 Purified telomerase
03/01/2000EP0981625A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
03/01/2000EP0981624A2 $i(LEISHMANIA) ANTIGENS FOR USE IN THE THERAPY AND DIAGNOSIS OF LEISHMANIASIS
03/01/2000EP0981623A1 Gene encoding for systemic acquired resistance in arabidopsis
03/01/2000EP0981622A1 A plant disease resistance signalling gene, materials and methods relating thereto
03/01/2000EP0981620A1 Hgf polypeptides and their use in therapy
1 ... 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 ... 2916